Cargando…
Prenatal Chromosomal Microarray Analysis: Does Increased Resolution Equal Increased Yield?
Chromosomal microarray analysis (CMA) is considered a first-tier test for patients with developmental disabilities and congenital anomalies and is also routinely applied in prenatal diagnosis. The current consensus size cut-off for reporting copy number variants (CNVs) in the prenatal setting ranges...
Autores principales: | Mitrakos, Anastasios, Kosma, Konstantina, Makrythanasis, Periklis, Tzetis, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454647/ https://www.ncbi.nlm.nih.gov/pubmed/37628571 http://dx.doi.org/10.3390/genes14081519 |
Ejemplares similares
-
Germline CNV Detection through Whole-Exome Sequencing (WES) Data Analysis Enhances Resolution of Rare Genetic Diseases
por: Tilemis, Faidon-Nikolaos, et al.
Publicado: (2023) -
NFB-17. "Optic Pathway findings in children with Neurofibromatosis type-1 (NF-1)
por: Roka, Kleoniki, et al.
Publicado: (2022) -
Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency
por: Wang, Chaohong, et al.
Publicado: (2022) -
Prenatal Diagnosis of Central Nervous System Anomalies by High-Resolution Chromosomal Microarray Analysis
por: Sun, Lijuan, et al.
Publicado: (2015) -
Application of chromosome microarray analysis in prenatal diagnosis
por: Xia, Mingjing, et al.
Publicado: (2020)